Overview

Overview
A decade ago, when China had not fully engaged in multi-center clinical trials, DIA came to China to host its first annual meeting in Beijing with the theme of “Drug Development in A Flat World:Innovation, Regulation and Globalization”. Since its inception in 2009, DIA China has committed to becoming a neutral forum in catalyzing knowledge creation and sharing to accelerate health product development in China. In the past two years, China Food and Drug Administration (CFDA) had demonstrated unprecedented resolve and determination of regulatory reform which had reached to the milestone of becoming regulatory member of ICH in June 2017. 

Do you want to be part of DIA Asia's largest interdisciplinary event in 2018? Do you want to contribute to the extraordinary event in the most encouraging era of life science innovation in China?  
 
Call for Topics
Call for Topics is now starting!  Join us and propose topics or sessions in 2018 the 10th DIA China Meeting:

·         Regulatory Science
·         Clinical Development
·         Quantitative Science
·         Medical Affairs
·         Therapeutic hot topics 
·         Generic Drugs
·         Pharmacovigilance 
·         Big Data Research and Artificial Intelligence in Healthcare 
·         Patient Engagement 
·         Translational Medicine
·         Hot Topics & Late Breaker

Topic submissions will be reviewed by the Annual Meeting Program Committee to assist with the content development and strategy for DIA China 2018. Submission of a topic is not in any way related to a speaking role at DIA China 2018. A Call for Abstracts will be available in the fall of 2017 to solicit sessions and presentations for DIA China 2018.
Topic submission deadline: August 31, 2017
所有提交的专题内容将经年会组委会进行审评与甄选,入选专题将成为第十届DIA中国年会内容开发和设计的专题。提交专题与第十届DIA中国年会的演讲角色无关。专题征集过后,2017年秋季第十届DIA中国年会将进一步针对各专题分会场和演讲进行摘要征集。
 
DIA作为一个全球知名的非营利专业协会,在药物研发、创新、临床研究,管理、法律法规,生产与市场开发等跨学科领域致力于广泛传播最新的医药知识和行业实时动向信息,成为推动知识创造和共享的中立论坛,加速中国健康产品的研究与开发,为促进药物研发的创新、提高健康与福祉的水平而努力。
Menu